C.F.R. homeSearch C.F.R.
C.F.R.Title 21Chapter I—Food and Drug Administration, Department of Health and Human ServicesSubchapter H—Medical DevicesPart 803—Medical Device ReportingSubpart A—General Provisions

21 C.F.R. § 803.1 (2026)

What does this part cover?

Edition and currency
eCFR text as of Sept. 29, 2026. The text is the edition Syfert holds; for a past event, check the version in force on that date.
Other sources
CURRENTeCFR text as of Sept. 29, 2026 cited 1994–2025 18citing cases
At a glance

Courts have cited this section in 18 opinions since 1994, 4 of them in the last five years.

(a) This part establishes the requirements for medical device reporting for device user facilities, manufacturers, importers, and distributors. If you are a device user facility, you must report deaths and serious injuries that a device has or may have caused or contributed to, establish and maintain adverse event files, and submit summary annual reports. If you are a manufacturer or importer, you must report deaths and serious injuries that your device has or may have caused or contributed to, you must report certain device malfunctions, and you must establish and maintain adverse event files. If you are a manufacturer, you must also submit specified followup. These reports help us to protect the public health by helping to ensure that devices are not adulterated or misbranded and are safe and effective for their intended use. If you are a medical device distributor, you must maintain records (files) of incidents, but you are not required to report these incidents.

(b) This part supplements and does not supersede other provisions of this chapter, including the provisions of part 820 of this chapter.

(c) References in this part to regulatory sections of the Code of Federal Regulations are to chapter I of title 21, unless otherwise noted.

The 18 cases that cite 21 C.F.R. § 803.1 most heavily, weighted by court and treatment. RelevanceNewestTreatment
1
GREENLori Nicholson v. Biomet, Inc., 46 F.4th 757 (8th Cir. 2022).
cites § 803.1 1×cited by 11 cases
Where it cites § 803.1
“8, 2022); see also 21 C.F.R. § 803.1 (a) (establishing requirements for medical device reporting).”
Later courts cite it for
“we review the district court's denial of a new trial for abuse of discretion.” · 2 citing courts
2
GREENWorthy v. Collagen Corp., 967 S.W.2d 360 (Tex. 1998).
cites § 803.1 1×cited by 68 cases
Where it cites § 803.1
“21 C.F.R. § 803.1 (1997). The FDA is authorized to notify the public of risks presented by medical devices, 21 U.”
The case’s holding
State law claims alleging liability despite a medical device's adherence to FDA-approved standards are preempted by federal requirements.
Later courts cite it for
“while a federal requirement would ordinarily not preempt general state common law requirements such as a duty of care or a duty to warn in the abstract, a federal requirement would preempt a particularized application of such duties that imposed a specific 'standard of care or behavior' different or in addition to the federal requirement.” · 3 citing courts
3
GREENSilver v. Medtronic, Inc., 236 F. Supp. 3d 889 (M.D. Pa. 2017).
cites § 803.1 1×cited by 10 cases
Where it cites § 803.1
“” 21 C.F.R. § 803.1 ; (Doc. 1, ¶¶ 78-80). Thus, the claim does not seek to impose additional warning requirements on Medtronic and would not be expressly preempted.”
4
GREENRollins v. St. Jude Med., 583 F. Supp. 2d 790 (W.D. La. 2008).
cites § 803.1 1×cited by 18 cases
Where it cites § 803.1
“Also, 21 C.F.R. § 803.1 (a) requires manufacturers to "report deaths and serious injuries that [the manufacturer's] device may have caused or contributed to, .”
Later courts cite it for
“may take judicial notice of and consider the public records of the fda ... without transforming a motion to dismiss into a motion for summary judgment.” · 2 citing courts
5
GREENUnited States v. LAERDAL Mfg. CORP., 73 F.3d 852 (9th Cir. 1995).
cites § 803.1 1×cited by 28 cases
Where it cites § 803.1
“In its findings of fact, the court determined that Laerdal had violated 21 C.F.R. § 803.1 (a) which requires a manufacturer to file a report with the Food and Drug Administration (“FDA”) “whenever information is received that reasonably suggests that a patient care device .”
Later courts cite it for
“past illegal conduct gives rise to an inference that future violations may occur” · 4 citing courts
6
GREENHawkins v. Medtronic, Inc., 909 F. Supp. 2d 901 (S.D. Ohio 2012).
cites § 803.1 1×cited by 12 cases
Where it cites § 803.1
“§ 360 (i) and 21 C.F.R. §§ 803.1 , 803.10, 803.50, 803.”
Later courts cite it for
“it was clear from the allegations that the plaintiff's claim is in fact prem ised upon the theory that defendant violated federal law.” · 2 citing courts
7
GREENArmstrong v. Optical Radiation Corp., 50 Cal. App. 4th 580 (Ct. App. 1996).
cites § 803.1 1×cited by 25 cases
Where it cites § 803.1
“” (See 21 C.F.R. § 803.1 (a) (1995) [requiring report to FDA if “one of [the manufacturer’s] marketed devices (1) may have caused or contributed to a death or serious injury or (2) has malfunctioned and that the device .”
The case’s holding
State law requirements for negligence and strict liability are based on general principles of state tort law rather than rules specifically developed for medical devices.
Later courts cite it for
“based on general principles of state tort law which were not specifically developed with respect to medical devices” · 1 citing court
8
GREENAngeles v. Medtronic, Inc., 863 N.W.2d 404 (Minn. Ct. App. 2015).
cites § 803.1 1×cited by 9 cases
Where it cites § 803.1
“See 21 C.F.R. § 803.1 -.58 (2014). Manufacturers must report specific adverse consequences, a summary of “[unpublished reports of data from any clinical investigation or nonclinical laboratory studies involving the device or related devices and known to or that reasonably should…”
9
GREENUnited States v. Laerdal Mfg. Corp., 853 F. Supp. 1219 (D. Or. 1994).
cites § 803.1 2×cited by 6 cases
Where it cites § 803.1
“21 C.F.R. § 803.1 (a). Under the MDR regulations, the manufacturer of a medical device who receives information that reasonably suggests that the device may have caused or contributed to a death or serious injury is required to notify the FDA by telephone within five calendar…”
10
GREENSteele v. Depuy Orthopaedics, Inc., 295 F. Supp. 2d 439 (D.N.J. 2003).
cites § 803.1 1×cited by 8 cases
Where it cites § 803.1
“39 ; see also 21 C.F.R. § 803.1 (requiring manufacturer to report “deaths and serious injuries” related to the operation of the device, to “maintain adverse event files,” and to submit to FDA “specified followup and summary reports”).”
11
GREENStevens v. Boston Sci. Corp., 152 F. Supp. 3d 527 (S.D. W. Va. 2016).
cites § 803.1 1×cited by 2 cases
Summary
No passage or summary on file for this case yet.
12
NEUTRALParkinson v. Guidant Corp., 315 F. Supp. 2d 754 (W.D. Pa. 2004).
cites § 803.1 1×cited by 3 cases
Where it cites § 803.1
“…medical devices to complete whenever there is a medical device related event that could involve patient consequences. 21 C.F.R. § 803.1 .”
Later courts cite it for
“the facts upon which the court must make its determination have been adequately presented to the court in the parties' papers and accompanying exhibits.” · 3 citing courts
13
NO FLAGKransky v. Depuy Orthopaedics, No. B249576 (Cal. Ct. App. July 21, 2016).
cites § 803.1 1×cited by 0 casesunpublished
Where it cites § 803.1
“, to the extent DePuy would have used this evidence to argue that it complied with post-market reporting requirements and that the FDA never mandated or requested a recall, Kransky, as he argued to the trial court, would have “present[ed] evidence of all of the complaints,…”
14
NO FLAGWhite v. Midway Med. Prods., Inc., No. 1:22-cv-03969 (N.D. Ill. Sept. 9, 2022).
cites § 803.1 1×cited by 0 casesunknown
Where it cites § 803.1
“For example, 21 C.F.R. § 803.1 states “[i]f you are a medical device distributor, you must maintain records (files) of incidents.”
15
NO FLAGJohns v. CR Bard, No. 2:18-cv-01509 (S.D. Ohio Dec. 3, 2020).
cites § 803.1 1×cited by 0 casesunknown
Where it cites § 803.1
“, 21 C.F.R. § 803.1 (a); see also FDA, Medical Device Reporting The protection and privacy of device user facilities appears to have been an important consideration for Congress in passing § 360i(b) in order to incentivize facilities to make such reports.”
16
NO FLAGKane v. Covidien LP, No. 2:23-cv-09207 (E.D.N.Y. Feb. 12, 2025).
cites § 803.1 1×cited by 0 casesunknown
Where it cites § 803.1
“) Defendants also point out that the Amended Complaint does not allege that the hospital staff documented the supposed Surgical Stapler failure, reported the failure to the FDA (as required by 21 C.F.R. § 803.1 ), or inspected the specific Surgical Stapler unit used in the…”
17
GREENPharm. Rsch. & Mfrs. of Am. v. Stolfi, 153 F.4th 795 (9th Cir. 2025).
cites § 803.1 1×cited by 0 cases
Where it cites § 803.1
“15 (requiring manufacturers of certain chemical substances to report information regarding chemical use and processing to the Environmental Protection Agency (“EPA”)); 21 C.F.R. §§ 803.1, 803.20 (requiring medical device manufacturers to report adverse medical events related to…”
Later courts cite it for
“in areas 'that have long been the source of public concern and the subject of government regulation.” · 2 citing courts
cites § 803.1 1×cited by 0 cases
Where it cites § 803.1
“See 21 C.F.R. § 803.1 -.58 20 (2014). Manufacturers must report specific adverse consequences, a summary of “[u]npublished reports of data from any clinical investigation or nonclinical laboratory studies involving the device or related devices and known to or that reasonably…”

The flag is Syfertize’s treatment of the citing case itself, not of the statute. “Where it cites” is the passage in the opinion; the holding is a summary of the whole case and may concern another point. Annotations are extracted automatically from the opinions in the Syfert caselaw corpus.

Citing cases by year
199420092025

One bar per year. Tallest: 2 cases in 2015. These are opinions in the Syfert collection, which holds more of some courts’ recent opinions than their older ones, so a rise can reflect what the collection holds and not more litigation.

By court
9th Cir.2Cal. Ct. App.2Minn. Ct. App.2S.D. Ohio28th Cir.1N.D. Ill.1W.D. La.1D.N.J.1

The 8 courts with the most citing cases, of 14 courts in all.

By subsection

Courts have not cited this section by subsection, so its cases are not split up here. The Leading cases tab lists the cases that cite it most heavily.

Enactment and amendments

Syfert holds no separate history line for this section. Where this code prints a source or history note, it appears with the text, usually at the end.

Versions

Edition shown: eCFR text as of Sept. 29, 2026. Syfert holds no earlier or later version of this section.

C.F.R. Home  |  Search C.F.R.  |  Search cases for this section  |  syfert.com